In 2008, the NIH Undiagnosed Diseases Program (UDP) was organized and established by the National Human Genome Research Institute (NHGRI), the National Institute of Health (NIH) Office of Rare Diseases Research (ORDR) and the NIH Clinical Center to help provide diagnosis and treatment for patients with unknown disorders.
In 2012, building on the success of this program in diagnosing both known and new diseases, the NIH Common Fund created the Undiagnosed Diseases Network (UDN) to test whether this type of cross-disciplinary approach to disease diagnosis is feasible to implement in academic medical centers around the United States.
The UDN will promote the use of genomic data in disease diagnosis and will engage basic researchers to elucidate the mechanisms underlying the diseases so that treatments may be identified. The program will also train clinicians in the use of contemporary genomic approaches so that genomic methods can increasingly be brought to bear on myriad diseases.
NIH names new clinical sites in Undiagnosed Diseases Network
Bethesda, Md., Tues., July 1, 2014 - The National Institutes of Health has awarded grants to six medical centers around the country to select from the most difficult-to-solve medical cases and together develop effective approaches to diagnose them. The clinical sites will conduct clinical evaluation and scientific investigation in cases that involve patients with prolonged undiagnosed conditions. Read more
Gene Function Studies to Investigate Rare and Undiagnosed Diseases
The current list of genes and diseases of interest to the Undiagnosed Diseases Network (UDN) for the FOA PA-13-076 [grants.nih.gov].
For information about the UDP, the NIH clinical site of the UDN, see: Undiagnosed Diseases Program
Last Updated: July 2, 2014